http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0302154-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4af3b58914d87c2cb87fbb281bc09428
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56988
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
filingDate 1987-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cdaeecfd79bbc9aa66adc53ea579554
publicationDate 1989-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0302154-A1
titleOfInvention Detection of HIV and anti-lymphocyte antibodies
abstract This invention relates to the detection of antibodies against HIV and anti-lymphocyte antibodies in sera of individuals previously exposed to HIV which react specifically with frozen section of HIV particles and normal blood lymphocytes. It is shown that the infection of human cells by HIV results in the production of antibodies which react specifically with HIV-core and the envelope thereof as well as with the surface and the intracellular structure of normal human blood lymphocytes. The presence, in biological specimens, of antibodies to the antigenic determinants localized on the HIV or blood lymphocytes is indicative of previous or current infection of an individual by HIV. Specifically, frozen sections of HIV and of the blood lymphocytes are specifically labelled by sera taken from individuals previously exposed to HIV. The preferred method of said detection of antibodies is by indirect immunofluorescence or by immunoperoxidase or by immunogold labelling.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1327885-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1327885-A1
priorityDate 1987-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0196873-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0015473-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8504903-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86726269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449702218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25199600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447827056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66898066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532689
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452599253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227323350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54487048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227038928
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721

Total number of triples: 30.